merck

With the Dow Jones Industrial Average finishing at a new closing high for a third straight day, you can bet on a lot of talk about stocks being frothy. But are they? Below are three different ways to spot stocks that may be frothy, and the top five identified by each marker. Some names recur...

Biotech stocks have proved to be volatile this year, and short sellers piled on Incyte (NASDAQ: INCY) between the April 15 and April 30 settlement dates. Pharmacyclics (NASDAQ: PCYC) and Regeneron Pharmaceuticals (NASDAQ: REGN) also saw double-digit percentage increases in the number of their...

U.S. stocks were mixed as Federal Reserve Chair Janet Yellen presented a prepared testimony which did not rattle investors. The Dow posted a triple-digit point gain after falling 43 points. The Nasdaq, on the other hand, declined as many momentum and Internet names were hit hard. Russian...

U.S. stocks declined on Tuesday after the Dow and S&P 500 closed near all time highs. Momentum names such as Twitter, Facebook, Tesla and others saw heavy losses. Not helping the cause was poor earnings by American International Group on Monday which dragged the financial sector lower....

U.S. stocks finished higher as the Dow approached its all time high of 16,631.60. The index trading on Tuesday as high as 16,559.39. The S&P 500 index is also not that far away from its all time highs of 1,897.28. The Federal Open Market Committee began its two-day meeting in Washington....

U.S. stocks ended the day mostly positive in a volatile trading session as the Nasdaq rebounded from a one percent decline, finishing the day almost flat. The Dow traded higher by as much as 138 points but still ended the day modestly higher as Pfizer's massive $100 billion takeover plans gave...

The earnings crunch continues this week. Among the highlights will be scheduled quarterly reports from Exxon Mobil and Chevron, from Bristol-Myers Squibb and Merck, from Time Warner and Viacom, and also from Twitter. Early Thursday, Exxon Mobil (NYSE: XOM) is expected to say that it had earnings...

Like Big Oil, Big Pharma has entered a period of consolidation. There are many factors contributing to this. First, it can be cheaper to buy a company with a promising product rather than undergo the costs of developing a drug. Add in low interest rates that make it cheap to borrow money to...

U.S. stocks inched higher as Apple's strong earnings reported on Wednesday proved to be not enough to ease fears over an escalating tension between Russia and Ukraine. Reports surfaced of escalated troop movements in Ukraine while Russia began military drills near the Ukraine border. After...

U.S. stocks rose to start off the holiday-filled shortened trading week on a positive note as investors found plenty of reason to be optimistic on retail sales which jumped the most since 2012. Investors were also encouraged by Citigroup's better than expected earnings which eased investor...

When it comes to the bio-tech, pharma and therapeutic sectors, the results from drug trials and the results from FDA evaluations can make or break stocks. On many occasions, the percentage leader and loser boards are littered with companies from these sectors that either released positive or...

After largely shying away in the previous period, short sellers found renewed interest in many of the leading biotech and emerging pharmaceutical companies between the February 28 and March 14 settlement dates. But Celgene (NASDAQ: CELG), Medivation (NASDAQ: MDVN) and Pharmacyclics (NASDAQ: PCYC...

The new year has proved to be a volatile one on the stock markets. After seeing a sizable correction in January, the S&P 500 and Dow Jones Industrial Average (DJIA) are again hitting or near all-time highs. Here is a quick look at the five top-performing Dow stocks in the past month. Note...

Pullbacks and sell-offs provide a perfect opportunity for investors who have faith in a company to snap up shares. Here are some stocks that have seen insider buying recently. Aircastle Japanese trading company Marubeni Corp. has been scooping up batches of Aircastle (NYSE: AYR) shares since last...

U.S. stocks overcame mixed economic data and earning reports as the S&P 500 inches towards new all time highs and the Dow recorded an almost triple digit point gain. Jobless claims declined less than expected while consumer prices met expectations and rose slightly. Data from the...